The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver disease in the Western world, probably due to the growing prevalence of obesity, metabolic diseases, and exposure to some environmental agents. In certain patients, simple hepatic steatosis can progress to non-alcoholic steatohepatitis (NASH), which can sometimes lead to liver cirrhosis and its complications including hepatocellular carcinoma. Understanding the mechanisms that cause the progression of NAFLD to NASH is crucial to be able to control the advancement of the disease. The main hypothesis considers that it is due to multiple factors that act together on genetically predisposed subjects to suffer from NAFLD including insulin resistance, nutritional factors, gut microbiota, and genetic and epigenetic factors. In this article, we will discuss the epidemiology of NAFLD, and we overview several topics that influence the development of the disease from simple steatosis to liver cirrhosis and its possible complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–254 of 254
DNA Methylation in Nonalcoholic Fatty Liver Disease
Hyun, J., & Jung, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218138 · Cited by 110
Corsini, E., Budello, S., Marabini, L., Galbiati, V., Piazzalunga, A., Barbieri, P., Cozzutto, S., Marinovich, M., Pitea, D., & Galli, C. L. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1071-z · Cited by 109
Stevanović, J., Beleza, J., Coxito, P. M., Ascensão, A. A. M. R., & Magalhães, J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.015 · Cited by 108
From the origin of NASH to the future of metabolic fatty liver disease
Geier, A., TINIAKOS, D. G., Denk, H., & Trauner, M. (2021) · Gut · doi:10.1136/gutjnl-2020-323202 · Cited by 106
Body mass index and waist circumference in non‐alcoholic fatty liver disease
Rocha, R., Cotrim, H. P., Carvalho, F. M., Siqueira, A. C., Braga, H., & de Freitas, L. A. R. (2005) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2005.00634.x · Cited by 105
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine
O’Hare, E. A., Yang, R., Yerges‐Armstrong, L. M., Sreenivasan, U., McFarland, R. J., Leitch, C. C., Wilson, M. H., Narina, S., Gorden, A., Ryan, K. A., et al. (2016) · Hepatology · doi:10.1002/hep.29021 · Cited by 101
The effects of second-hand smoke on biological processes important in atherogenesis
Yuan, H., Wong, L., Bhattacharya, M., Ma, C., Zafarani, M., Yao, M., Schneider, M., Pitas, R. E., & Martins‐Green, M. M. (2007) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-7-1 · Cited by 99
Choi, J. M., Seo, M., Kyeong, H., Kim, E.-K., & Kim, H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300457110 · Cited by 96
Modification of Insulin Sensitivity and Glycemic Control by Activity and Exercise
ROBERTS, C. K., LITTLE, J. P., & THYFAULT, J. P. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318295cdbb · Cited by 95
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease
Bayoumi, A., Grønbæk, H., George, J., & Eslam, M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.03.003 · Cited by 92
Gellert‐Kristensen, H., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Stender, S. (2019) · Hepatology · doi:10.1002/hep.30799 · Cited by 91
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study
Cui, J. Y., Chen, C., Lo, M., Schork, N. J., Bettencourt, R., Gonzalez, M. P., Bhatt, A., Hooker, J. C., Shaffer, K. M., Nelson, K. E., et al. (2016) · Hepatology · doi:10.1002/hep.28674 · Cited by 90
Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational Study
Drinda, S., Grundler, F., Neumann, T. E., Lehmann, T., Steckhan, N., Michalsen, A., & de Toledo, F. W. (2019) · Nutrients · doi:10.3390/nu11112601 · Cited by 88
Tsochatzis, E. A., Papatheodoridis, G., Manesis, E. K., Kafiri, G., TINIAKOS, D. G., & Archimandritis, A. J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03538.x · Cited by 87
Role of HSD17B13 in the liver physiology and pathophysiology
Su, W., Mao, Z., Liu, Y., Zhang, X., Zhang, W., Gustafsson, J.-Α., & Guan, Y. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.014 · Cited by 85
17β-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein
Horiguchi, Y., Araki, M., & Motojima, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.063 · Cited by 84
Kim, D. S., Jackson, A. U., Li, Y. K., Stringham, H. M., Kuusisto, J., Kangas, A. J., Soininen, P., Ala‐Korpela, M., Burant, C., Salomaa, V. V., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.p076034 · Cited by 83
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
Borén, J., Adiels, M., Björnson, E., Matikainen, N., Söderlund, S., Rämö, J., Ståhlman, M., Ripatti, P., Ripatti, S., Palotie, A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.144079 · Cited by 81 · cited 8×
“The augmented free fatty acid uptake in the liver results from high energy diet, increased lipolysis of adipose tissue, and de novo hepatic lipogenesis, while output mechanisms related with fatty acid oxidation and very low-density lipoproteins secretion (VLDL) remain insufficient to compensate for the accumulation of…”
BackgroundInfluentialViganò, M., Valenti, L. V. C., Lampertico, P., Facchetti, F., Motta, B. M., D’Ambrosio, R., Romagnoli, S., Dongiovanni, P., Donati, B., Fargion, S. R., et al. (2013) · Hepatology · doi:10.1002/hep.26445 · Cited by 79
Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 78
Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?
Finelli, C., & Tarantino, G. (2012) · PubMed · Cited by 77
Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis
Viscarra, J. A., Wang, Y., Nguyen, H. P., Choi, Y. G., & Sul, H. S. (2020) · Nature Communications · doi:10.1038/s41467-020-14617-1 · Cited by 77
Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes
Wittenbecher, C., Ouni, M., Kuxhaus, O., Jähnert, M., Gottmann, P., Teichmann, A., Meidtner, K., Kriebel, J., Grallert, H., Pischon, T., et al. (2019) · Diabetes · doi:10.2337/db18-0620 · Cited by 76
The influence of PM2.5 exposure on non-alcoholic fatty liver disease
Chen, J., Wu, L., Yang, G., Zhang, C., Liu, X., Sun, X., Chen, X., & Wang, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119135 · Cited by 75
Hepatic Steatosis and Increased Adiposity in Mice Consuming Rapidly vs. Slowly Absorbed Carbohydrate
Scribner, K. B., Pawlak, D. B., & Ludwig, D. S. (2007) · Obesity · doi:10.1038/oby.2007.260 · Cited by 74
Tsochatzis, E. A., Papatheodoridis, G., Manesis, E. K., Kafiri, G., & Archimandritis, A. J. (2007) · Journal of Hepatology · doi:10.1016/s0168-8278(07)62365-4 · Cited by 73
Valenti, L. V. C., Alisi, A., & Nobili, V. (2012) · Hepatology · doi:10.1002/hep.25617 · Cited by 72
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes
Käräjämäki, A. J., Bloigu, R., Kauma, H., Kesäniemi, Y. A., Koivurova, O., Perkiömäki, J. S., Huikuri, H. V., & Ukkola, O. H. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.009 · Cited by 72
Loomba, R. S., Rao, F., Zhang, L., Khandrika, S., Ziegler, M. G., Brenner, D. A., & O’Connor, D. T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.009 · Cited by 69
Liver fibrosis: the 2017 state of art
Caviglia, G. P., Rosso, C., Fagoonee, S., Saracco, G. M., & Pellicano, R. (2017) · Panminerva Medica · doi:10.23736/s0031-0808.17.03359-6 · Cited by 68
Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease
Baker, P. R., & Friedman, J. E. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120846 · Cited by 68
Folkmann, J. K., Risom, L., Hansen, C. S., Loft, S. H., & Möller, P. (2007) · Toxicology · doi:10.1016/j.tox.2007.05.009 · Cited by 64
TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease
Sanchez-Pulido, L., & Ponting, C. P. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00439 · Cited by 63
Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism
Kim, H., Méndez, R., Chen, X., Fang, D., & Zhang, K. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00665-15 · Cited by 61
Kammel, A., Saussenthaler, S., Jähnert, M., Jonas, W., Stirm, L., Hoeflich, A., Staiger, H., Fritsche, A., Häring, H., Joost, H., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw121 · Cited by 61
Milano, M., Aghemo, A., Mancina, R. M., Fischer, J., Dongiovanni, P., Nicola, S. D., Fracanzani, A. L., D’Ambrosio, R., Maggioni, M., Francesco, R. D., et al. (2015) · Hepatology · doi:10.1002/hep.27811 · Cited by 59
Yang, Z. H., Wen, J., Tao, X., Lü, B., Du, Y., Wang, M., Wang, X., Zhang, W., Gong, W., Ling, C., et al. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0212-1 · Cited by 59
Μantaka, A., Koulentaki, M., CHLOUVERAKIS, G. I., Enele-Melono, J. M., Darivianaki, A., Tzardi, M. N., & Kouroumalis, E. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-110 · Cited by 58
MBOAT7 is anchored to endomembranes by six transmembrane domains
Caddeo, A. M., Jamialahmadi, O., Solinas, G., Pujia, A., Mancina, R. M., Pingitore, P., & Romeo, S. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.04.006 · Cited by 58
The benefits of exercise for patients with non-alcoholic fatty liver disease
Keating, S. E., George, J., & Johnson, N. A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1075392 · Cited by 53
Nutritional Assessments of Patients with Non-alcoholic Fatty Liver Disease
Kim, C. H., Kallman, J. B., Bai, C., Pawloski, L. R., Gewa, C., Arsalla, A., Sabatella, M. E., & Younossi, Z. M. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9549-0 · Cited by 52
Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes
Grønbæk, H., Thomsen, K. L., Rungby, J., Schmitz, O., & Vilstrup, H. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.5.705 · Cited by 50
Kim, Y. S., Nam, H. J., Han, C. Y., Joo, M. S., Jang, K., Jun, D. W., & Kim, S. G. (2020) · Hepatology · doi:10.1002/hep.31423 · Cited by 45
Long, M. T., Gurary, E. B., Massaro, J. M., Ma, J., Hoffmann, U., Chung, R. T., Benjamin, E. J., & Loomba, R. S. (2018) · Liver International · doi:10.1111/liv.13956 · Cited by 43
Tabibian, J. H., Lazo, M., Durazo, F. A., Yeh, H. C., Tong, M. J., & Clark, J. M. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06443.x · Cited by 36
Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis
Kozlitina, J. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.09.001 · Cited by 33
Survey of health status, nutrition and geography of food selection of chronic liver disease patients
Leslie, T. F., Pawloski, L. R., Kallman-Price, J., Escheik, C., Hossain, N., Fang, Y. H., Gerber, L. H., & Younossi, Z. M. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31253-0 · Cited by 28
Hosoyamada, K., Uto, H., Imamura, Y., Hiramine, Y., Toyokura, E., Hidaka, Y., Kuwahara, T., Kusano, K., Saito, K., Oketani, M., et al. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-34 · Cited by 21
Balakrishnan, M., Kanwal, F., El‐Serag, H. B., & Thrift, A. P. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.09.149 · Cited by 21
Cartier, J., Smith, T. S., Thomson, J. P., Rose, C. M., Khulan, B., Heger, A., Meehan, R. R., & Drake, A. J. (2018) · Genome biology · doi:10.1186/s13059-018-1422-4 · Cited by 21
How does obesity lead to insulin resistance?
Choi, C. H. J., & Cohen, P. (2017) · eLife · doi:10.7554/elife.33298 · Cited by 20
Xenobiotic Exposure and Autoimmune Hepatitis
Gilbert, K. M. (2010) · Hepatitis Research and Treatment · doi:10.1155/2010/248157 · Cited by 18
Zhang, H., Jiang, Y., He, S.-M., Sun, J. L., Gu, Q., Feng, X.-W., Bing, D. U., Wang, W., Shi, X., Wang, C., et al. (2011) · PubMed · Cited by 16
Wang, R., Lü, Q., Feng, J., Yin, F., Qin, C., Liu, B., Liu, Y., & Liu, X. (2011) · Endocrine · doi:10.1007/s12020-011-9511-0 · Cited by 16
Cited by
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
Mahapatro, A., Bawna, F., Kumar, V., Daryagasht, A. A., Gupta, S., Raghuma, N., Moghdam, S. S., Kolla, A., Mahapatra, S. S., Sattari, N., et al. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.07.087 · Cited by 37
Liver abnormalities in Turner syndrome: the importance of estrogen replacement
Fedor, I., Zold, E., & Barta, Z. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac124 · Cited by 16
“NAFLD is frequently associated with metabolic syndrome and is otherwise defined by the presence of excess intrahepatic fat deposits, not attributable to the consumption of alcoholic beverages [24, 25].”
Background
Metadata
- Authors
- Juanola, O., Martínez-López, S., Francés, R., & Gómez-Hurtado, I.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2021-05-14
- Volume
- 18
- Issue
- 10
- Pages
- 5227
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W3163776584
- Cited by
- 302
- References
- 254
- FWCI
- 29.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.